Literature DB >> 20555035

Multiple endocrine neoplasia type 1 deletion in pancreatic alpha-cells leads to development of insulinomas in mice.

H-C Jennifer Shen1, Kris Ylaya, Klaus Pechhold, Arianne Wilson, Asha Adem, Stephen M Hewitt, Steven K Libutti.   

Abstract

The pancreatic alpha- and beta-cells are critical components in regulating blood glucose homeostasis via secretion of glucagon and insulin, respectively. Both cell types are typically localized in the islets of Langerhans. However, little is known about the roles of paracrine interactions that contribute to their physiological functions. The lack of suitable cell lines to study alpha- and beta-cells interactions have led us to develop an alpha-cell-specific Cre-expressing transgenic line utilizing a glucagon promoter sequence, the Glu-Cre transgenic mouse. Here, we demonstrate that the Glu-Cre could specifically and efficiently excise floxed target genes in adult islet alpha-cells. We further showed that deletion of the tumor suppressor gene, multiple endocrine neoplasia type 1 (Men1), in alpha-cells led to tumorigenesis. However, to our surprise, the lack of Men1 in alpha-cells did not result in glucagonomas but rather beta-cell insulinomas. Because deletion of the Men1 alleles was only present in alpha-cells, our data suggested that cross communication between alpha- and beta-cells contributes to tumorigenesis in the absence of Men1. Together, we believed that the new model systems described here will allow future studies to decipher cellular interactions between islet alpha- and beta-cells in a physiological context.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20555035      PMCID: PMC2940531          DOI: 10.1210/en.2009-1251

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  26 in total

1.  A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.

Authors:  J S Crabtree; P C Scacheri; J M Ward; L Garrett-Beal; M R Emmert-Buck; K A Edgemon; D Lorang; S K Libutti; S C Chandrasekharappa; S J Marx; A M Spiegel; F S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

Review 2.  Pancreatic cell lineage analyses in mice.

Authors:  Pedro L Herrera; Virginie Nepote; Alexandra Delacour
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

3.  Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development.

Authors:  Jieli Lu; Pedro L Herrera; Christine Carreira; Rémy Bonnavion; Christelle Seigne; Alain Calender; Philippe Bertolino; Chang Xian Zhang
Journal:  Gastroenterology       Date:  2010-02-02       Impact factor: 22.682

4.  Of mice and MEN1: Insulinomas in a conditional mouse knockout.

Authors:  Judy S Crabtree; Peter C Scacheri; Jerrold M Ward; Sara R McNally; Gary P Swain; Cristina Montagna; Jeffrey H Hager; Douglas Hanahan; Helena Edlund; Mark A Magnuson; Lisa Garrett-Beal; A Lee Burns; Thomas Ried; Settara C Chandrasekharappa; Stephen J Marx; Allen M Spiegel; Francis S Collins
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

5.  Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene.

Authors:  Wenbin Ma; Lino Tessarollo; Seung-Beom Hong; Masaya Baba; Eileen Southon; Timothy C Back; Sally Spence; Corrinne G Lobe; Nirmala Sharma; Gregory W Maher; Svetlana Pack; Alexander O Vortmeyer; Chuanfa Guo; Berton Zbar; Laura S Schmidt
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

6.  Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice.

Authors:  Philippe Bertolino; Wei-Min Tong; Pedro Luis Herrera; Huguette Casse; Chang Xian Zhang; Zhao-Qi Wang
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

7.  Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism.

Authors:  Steven K Libutti; Judy S Crabtree; Dominique Lorang; A Lee Burns; Chiara Mazzanti; Stephen M Hewitt; Sarah O'Connor; Jerrold M Ward; Michael R Emmert-Buck; Alan Remaley; Marshall Miller; Ewa Turner; H Richard Alexander; Andrew Arnold; Stephen J Marx; Francis S Collins; Allen M Spiegel
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

8.  Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1.

Authors:  Philippe Bertolino; Wei-Min Tong; Dominique Galendo; Zhao-Qi Wang; Chang-Xian Zhang
Journal:  Mol Endocrinol       Date:  2003-06-20

9.  Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues.

Authors:  Christine A Biondi; Michael G Gartside; Paul Waring; Kelly A Loffler; Mitchell S Stark; Mark A Magnuson; Graham F Kay; Nicholas K Hayward
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

10.  Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages.

Authors:  P L Herrera
Journal:  Development       Date:  2000-06       Impact factor: 6.868

View more
  20 in total

Review 1.  Deconstructing pancreas developmental biology.

Authors:  Cecil M Benitez; William R Goodyer; Seung K Kim
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-06-01       Impact factor: 10.005

2.  The embryonic transcription factor Hlxb9 is a menin interacting partner that controls pancreatic β-cell proliferation and the expression of insulin regulators.

Authors:  Kerong Shi; Vaishali I Parekh; Swarnava Roy; Shruti S Desai; Sunita K Agarwal
Journal:  Endocr Relat Cancer       Date:  2013-02-18       Impact factor: 5.678

3.  Exploring the tumors of multiple endocrine neoplasia type 1 in mouse models for basic and preclinical studies.

Authors:  Sunita K Agarwal
Journal:  Int J Endocr Oncol       Date:  2014

Review 4.  Pathophysiology of Gastric NETs: Role of Gastrin and Menin.

Authors:  Sinju Sundaresan; Anthony J Kang; Juanita L Merchant
Journal:  Curr Gastroenterol Rep       Date:  2017-07

5.  Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma.

Authors:  S T Glenn; C A Jones; S Sexton; C M LeVea; S M Caraker; G Hajduczok; K W Gross
Journal:  Oncogene       Date:  2013-12-02       Impact factor: 9.867

6.  GSK-3β protein phosphorylates and stabilizes HLXB9 protein in insulinoma cells to form a targetable mechanism of controlling insulinoma cell proliferation.

Authors:  Shruti S Desai; Sita D Modali; Vaishali I Parekh; Electron Kebebew; Sunita K Agarwal
Journal:  J Biol Chem       Date:  2014-01-14       Impact factor: 5.157

7.  Men1 maintains exocrine pancreas homeostasis in response to inflammation and oncogenic stress.

Authors:  Amanda R Wasylishen; Chang Sun; Gilda P Chau; Yuan Qi; Xiaoping Su; Michael P Kim; Jeannelyn S Estrella; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-10       Impact factor: 11.205

Review 8.  The future: genetics advances in MEN1 therapeutic approaches and management strategies.

Authors:  Sunita K Agarwal
Journal:  Endocr Relat Cancer       Date:  2017-10       Impact factor: 5.678

Review 9.  MENIN loss as a tissue-specific driver of tumorigenesis.

Authors:  Janet W Y Li; Xianxin Hua; Diane Reidy-Lagunes; Brian R Untch
Journal:  Mol Cell Endocrinol       Date:  2017-09-28       Impact factor: 4.102

Review 10.  Multiple Endocrine Neoplasia Type 1: Latest Insights.

Authors:  Maria Luisa Brandi; Sunita K Agarwal; Nancy D Perrier; Kate E Lines; Gerlof D Valk; Rajesh V Thakker
Journal:  Endocr Rev       Date:  2021-03-15       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.